Showing results (11-20 of 70) with videos related to
Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|August 17, 2004
Phase I study of green tea extract in patients with advanced lung cancerScott A Laurie, Vincent A Miller, Stefan C Grant, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gefitinib (IRESSA) with vinorelbine or vinorelbine/cisplatin for chemotherapy-naive non-small cell lung cancer patientsJean-Louis Pujol, Patrick Viens, Paul Rebattu, et al.Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|November 15, 2013
Ocular metastasis of lung adenocarcinoma with ELM4-ALK translocation: A case report with a review of the literatureKailun Jiang, Seymour Brownstein, Harmanjatinder S Sekhon, et al.Clinical Lung Cancer|January 28, 2014
Prognostic factors in the radical nonsurgical treatment of stage IIIB non-small-cell lung cancerKent Russell, Brian Healy, Jason Pantarotto, et al.Pharmaceuticals (Basel, Switzerland)|December 31, 2025
First-in-Human Phase I Clinical Trial of SLC-391, a Novel and Selective AXL Inhibitor, in Patients with Advanced Solid TumoursZaihui Zhang, Donna Morrison, Liang Lu, et al.Lung Cancer International|August 29, 2015
Malignant Pleural Mesothelioma Outcomes in the Era of Combined Platinum and Folate Antimetabolite ChemotherapyMathieu D Saint-Pierre, Christopher Pease, Hamid Mithoowani, et al.Journal of Cutaneous Pathology|August 5, 2015
Primary cutaneous adenoid cystic carcinoma with brain metastases: case report and literature reviewLaura D Pozzobon, Rafael Glikstein, Scott A Laurie, et al.Clinical Lung Cancer|July 2, 2017
The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung CancerSharon F McGee, Tinghua Zhang, Hannah Jonker, et al.Clinical Lung Cancer|August 8, 2012
Chemoradiotherapy for locoregional recurrence of non-small-cell lung cancer after surgical resection: a retrospective analysisJair Bar, Dawn Ng, Patricia Moretto, et al.Clinical Lung Cancer|June 5, 2012
A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancerPeter M Ellis, Quincy S Chu, Natasha Leighl, et al.Pageof 7